Masimo & University Hospitals Unite For Patient Monitoring

 | Mar 23, 2020 09:49PM ET

Masimo Corporation (NASDAQ:MASI) and University Hospitals recently collaborated to implement MasimoSafetyNet to help clinicians monitor patients remotely.
Notably, MasimoSafetyNet is a telehealth solution that combines the Radius PPG pulse oximetry. The solution functions through Masimo SET Measure-through Motion and Low Perfusion technology and Doctella. It is also accessible on smartphones.
Rationale Behind the Tie-Up
Investors are already aware that the coronavirus (COVID-19) pandemic has wreaked havoc over the past month. Resultantly, an increasing number of U.S. states are undergoing lockdown while a nationwide lockdown isn’t far.
Given the situation, monitoring patients remotely by clinicians is likely to become a challenge.
Masimo’s latest collaboration is likely to ramp up the demand for its patient monitoring systems, thereby facilitating remote monitoring at patients’ homes.
This also boosts Masimo’s patient monitoring product spectrum, which includes Rainbow Pulse CO-Oximetry, Rainbow acoustic monitoring, SedLine brain function monitoring, and capnography and gas monitoring.
Other Developments
Masimo has seen a plethora of developments lately.
The company is providing discounts on its Rainbow platform to help customers manage blood supplies. This is likely to tackle the blood shortage due to the COVID-19 outbreak worldwide.
Also, the company recently acquired Germany’s TNI medical. Notably, TNI’s novel softFlow is expected to boost Masimo’s respiratory care product portfolio. The COVID-19 wave has ramped up demand for TNI’s softFlow technology. Hence, this technology will provide Masimo with additional tools to address the growing number of people affected by pulmonary diseases.
Moreover, the company recently inked a deal with Imprivata with respect to the integration of Imprivata Medical Device Access into Masimo’s Hospital Automation solutions that feature the Root Patient Monitoring and Connectivity Platform.